8
Participants
Start Date
January 31, 2016
Primary Completion Date
March 31, 2016
Study Completion Date
March 31, 2016
Oral Testosterone Undecanoate
Subjects will receive a single dose containing 158 mg of testosterone undecanoate, equivalent to 200 mg testosterone.
Los Angeles Biomedical Research Institute, Torrance
Lead Sponsor
Clarus Therapeutics, Inc.
INDUSTRY